相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Design, Synthesis, and Biological Evaluation of the First Radio- Metalated Neurotensin Analogue Targeting Neurotensin Receptor 2
Sacha Bodin et al.
ACS OMEGA (2023)
Cancer statistics, 2023
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2023)
Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer
Isabel Heidegger et al.
MOLECULAR CANCER (2022)
Comparison of 68Ga-PSMA-617 PET/CT and 68Ga-RM2 PET/CT in patients with localized prostate cancer candidate for radical prostatectomy: a prospective, single arm, single center, phase II study
Romain Schollhammer et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
68Ga-Radiolabeling and Pharmacological Characterization of a Kit-Based Formulation of the Gastrin-Releasing Peptide Receptor (GRP-R) Antagonist RM2 for Convenient Preparation of [68Ga]Ga-RM2
Adrien Chastel et al.
PHARMACEUTICS (2021)
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study
Michael S. Hofman et al.
LANCET (2020)
Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy
Benedikt Judmann et al.
PHARMACEUTICALS (2020)
Silicon-Containing Neurotensin Analogues as Radiopharmaceuticals for NTS1-Positive Tumors Imaging
Roberto Fanelli et al.
BIOCONJUGATE CHEMISTRY (2020)
Development of Bispecific NT-PSMA Heterodimer for Prostate Cancer Imaging: A Potential Approach to Address Tumor Heterogeneity
Xiaofen Ma et al.
BIOCONJUGATE CHEMISTRY (2019)
Neurotensin Receptor-1 Expression in Human Prostate Cancer: A Pilot Study on Primary Tumors and Lymph Node Metastases
Clement Morgat et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Preclinical Evaluation of 68Ga-DOTA-NT-20.3: A Promising PET Imaging Probe To Discriminate Human Pancreatic Ductal Adenocarcinoma from Pancreatitis
Aurelie Prignon et al.
MOLECULAR PHARMACEUTICS (2019)
Evaluation of neurotensin receptor 1 as potential biomarker for prostate cancer theranostic use
Tingting He et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Comparison of the radiolabeled PSMA-inhibitor 111In-PSMA-617 and the radiolabeled GRP-R antagonist 111In-RM2 in primary prostate cancer samples
Romain Schollhammer et al.
EJNMMI RESEARCH (2019)
Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist 68Ga-RM2 and 18F-FDG in breast cancer samples
Clement Morgat et al.
PLOS ONE (2019)
Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer
Karim A. Touijer et al.
EUROPEAN UROLOGY ONCOLOGY (2019)
68Ga-PSMA-617 PET/CT: a promising new technique for predicting risk stratification and metastatic risk of prostate cancer patients
Chen Liu et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Update on 18F-Fluciclovine PET for Prostate Cancer Imaging
Ephraim E. Parent et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Highly Increased 125I-JR11 Antagonist Binding In Vitro Reveals Novel Indications for sst2 Targeting in Human Cancers
Jean Claude Reubi et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Expression of Gastrin-Releasing Peptide Receptor in Breast Cancer and Its Association with Pathologic, Biologic, and Clinical Parameters: A Study of 1,432 Primary Tumors
Clement Morgat et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Goteborg Randomised Screening Trial
Anna Grenabo Bergdahl et al.
EUROPEAN UROLOGY (2016)
Evaluation of Prostate Cancer with 11C- and 18F-Choline PET/CT: Diagnosis and Initial Staging
Sascha Nitsch et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Current use of PSMA - PET in prostate cancer management
Tobias Maurer et al.
NATURE REVIEWS UROLOGY (2016)
The influence of different metal-chelate conjugates of pentixafor on the CXCR4 affinity
Andreas Poschenrieder et al.
EJNMMI RESEARCH (2016)
Improved radiosynthesis and preliminary in vivo evaluation of a 18F-labeled glycopeptide-peptoid hybrid for PET imaging of neurotensin receptor 2
Simone Maschauer et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature
Jurgen J. Futterer et al.
EUROPEAN UROLOGY (2015)
Comparison of MR/Ultrasound Fusion-Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer
M. Minhaj Siddiqui et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer
Martina Benesova et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Twins in spirit - episode I: comparative preclinical evaluation of [68Ga]DOTATATE and [68Ga]HA-DOTATATE
Margret Schottelius et al.
EJNMMI RESEARCH (2015)
CXCR4 Expression in Prostate Cancer Progenitor Cells
Anna Dubrovska et al.
PLOS ONE (2012)
Altered Expression of Neurotensin Receptors Is Associated with the Differentiation State of Prostate Cancer
Stephanie L. Swift et al.
CANCER RESEARCH (2010)
IMMUNOHISTOCHEMICAL EXPRESSION AND LOCALIZATION OF SOMATOSTATIN RECEPTOR SUBTYPES IN PROSTATE CANCER WITH NEUROENDOCRINE DIFFERENTIATION
D. Morichetti et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2010)
分享论文
